Registration is now open for RNA Therapeutics 2022
SMi Group reports: The 13th Annual RNA Therapeutics Conference is set to return in February 2022 with a key focus on the latest advances and opportunities in RNA-based medicine.
By: SMi Group
Chair for the conference is industry expert Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech.
New to 2022 is the RNA Therapeutics Focus Day on: "Vaccines in the RNA Industry" taking place on 8th February 2022.This will explore the latest advances in vaccine development. The focus day is chaired by Steve Pascolo, Founder and CEO at Miescher Pharma.
Interested parties can register for the conference and focus day at www.therapeutics-
The conference will also bring two cutting-edge panel discussions on
1. The Evolution and Expansion of RNA-based Therapeutics
2. The Successes and Failures of RNA-based Therapeutics and Future Outlook
By attending the conference attendees will have the opportunity to
Building on the success of previous years, SMi's 13th Annual RNA Therapeutics Conference will bring together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments of the industry.
View the agenda and speaker line – up at www.therapeutics-
Sponsors: BIA Separations & eTheRNA Immunotherapies
For sponsorship enquiries contact Alia Malick, Director on +44 (0)20 7827 6164 or e-mail amalick@smi-
For media enquiries or a press pass contact Marketing, Nikisha Galoria on +44 (0) 20 7827 6154 or email ngaloria@smi-